Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00224965 · ClinicalTrials.gov registry record · Phase 1

Early Tobacco Abstinence - 5

A Phase 1 study, sponsored by National Institute on Drug Abuse (NIDA).

Terminated
Registry status
Phase 1
Development phase
140
Enrollment target

NCT00224965 is a Phase 1 study that was terminated before completion, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 140 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00224965, a Phase 1 study, was terminated before completion, sponsored by National Institute on Drug Abuse (NIDA).

TERMINATED
Registry status
Phase 1
Development phase
140 participants
Enrollment target

Study Summary

This proposal will conduct a prospective examination of the clinical course (intensity, content and duration) of tobacco (nicotine) abstinence effects in male and female smokers who are either heavy/light alcohol drinkers with/without depressive symptoms.

Interventions

  • BEHAVIORAL Behavior Therapy

Trial Details

FieldValue
Enrollment Target 140 participants
Est. Completion 2004-10
Phase Phase 1

What the Registry Record Tells You About NCT00224965

The ClinicalTrials.gov registry entry for NCT00224965 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Behavior Therapy is the first listed.

NCT00224965 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00224965 about?

NCT00224965 is a clinical study titled "Early Tobacco Abstinence - 5". This proposal will conduct a prospective examination of the clinical course (intensity, content and duration) of tobacco (nicotine) abstinence effects in male and female smokers who are either heavy/light alcohol drinkers with/without depressive symptoms.

What is the current status of trial NCT00224965?

This trial is currently terminated. It is a Phase 1 study. The enrollment target is 140 participants. Estimated completion is 2004-10.

What interventions are being tested in trial NCT00224965?

The interventions under investigation include: Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00224965?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.